NCT07097025View on ClinicalTrials.gov

2-Year Study of Vagus Nerve Stimulation for Higher-Grade Treatment-Resistant Depression: Clinical Outcomes and Policy Recommendation

CompletedOBSERVATIONAL
Enrollment

19

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Treatment Resistant Depression (TRD)Depression - Major Depressive DisorderBipolar Depression
Interventions
DEVICE

vagus nerve stimulation

VNS is a neuromodulatory treatment involving implantation of a subcutaneous device that delivers intermittent electrical stimulation to the vagus nerve, modulating central pathways associated with mood regulation.

Trial Locations (2)

4281000

Lev Hasharon Medical Center, Netanya

5154475

Maaynei Hayeshua medical center, Bnei Brak

All Listed Sponsors
collaborator

Lev HaSharon Mental Health Center

UNKNOWN

collaborator

Maaynei Hayesha Medical Center

OTHER

lead

Dr.Yoav Domany

OTHER

NCT07097025 - 2-Year Study of Vagus Nerve Stimulation for Higher-Grade Treatment-Resistant Depression: Clinical Outcomes and Policy Recommendation | Biotech Hunter | Biotech Hunter